Plegridy (peginterferon beta-1a) is an injection used to treat relapsing-remitting multiple sclerosis (MS) in adults aged 18 years or over. It's a modified, long-acting form of interferon, which is a natural substance that helps protect against infections and diseases.
Plegridy is administered as a self-injection under the skin every two weeks. It comes in single-use pre-filled pens, and a nurse will teach you how to use it. Plegridy offers flexibility in choosing your injection day as long as it's done every 14 days.
Key features of Plegridy include:
- Low dosing frequency: You inject Plegridy only once every two weeks.
- Self-injection: You can administer the injection yourself, offering convenience and flexibility.
- Pre-filled pens: The medication comes in ready-to-use pens for easy administration.
